Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 1

Interventions

Specimen Handling 480 pembrolizumab 455 Magnetic Resonance Spectroscopy 420 Carboplatin 327 Cyclophosphamide 314 Cisplatin 271 Biopsy 271 Radiotherapy 244 Paclitaxel 229 Gemcitabine 227 Bevacizumab 213 Nivolumab 188 fludarabine 185 venetoclax 174 Drug Therapy 170 Blood Specimen Collection 158 Dexamethasone 157 Oxaliplatin 154 Injections 152 Capecitabine 151 Fluorouracil 144 Docetaxel 144 Radiosurgery 137 Standard of Care 135 Rituximab 125 Pemetrexed 117 durvalumab 115 Leucovorin 109 atezolizumab 107 Radiation 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × green tea extract polyphenone E × 1 year × Clear all

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡